Work

Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era

Year: 2026

Type: article

Abstract: This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.

Source: JAMA Surgery

DOI: 10.1001/jamasurg.2026.0049

Authors: Stefanie C. Rohde, Grace F. Chao, Mahmoud Abdel-Rasoul, Mohamed I. Elsaid, Patrick J. Sweigert

Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, Atrium Health Wake Forest Baptist, Wake Forest University Health Sciences, Wake Forest University

Language: English

Topic: Bariatric Surgery and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7133509873

FWCI: 78.16

Cites: 3

Cited by: 12

Related to: